Eikonizo Therapeutics Inc

Eikonizo Therapeutics, Inc. develops biotechnology and pharmaceutical solutions for neurodegenerative and cardiorenal diseases. The Company advances selective HDAC6 inhibitors and conducts preclinical and clinical research to validate these approaches. Eikonizo Therapeutics Inc serves patients in the United States.